(Q37810424)

English

Review of the ESPRIT study: aspirin plus dipyridamole versus aspirin alone for prevention of vascular events after a noncardioembolic, mild-to-moderate ischemic stroke or transient ischemic attack

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Review of the ESPRIT study: aspirin plus dipyridamole versus aspirin alone for prevention of vascular events after a noncardioembolic, mild-to-moderate ischemic stroke or transient ischemic attack (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

based on heuristic

inferred from title

author name string

Halina White

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Dara G Jamieson

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

0 references

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Postgraduate Medicine

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

122

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

227-229

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2238

21 January 2018

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2238

21 January 2018

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2238

21 January 2018

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2238

21 January 2018

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2238

21 January 2018

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2238

21 January 2018

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2238

21 January 2018

Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2238

21 January 2018

Identifiers

10.3810/PGM.2010.11.2238

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37810424&oldid=1728858329"